There’s a good chance that Berkshire Hathaway’s stock will lag the S&P 500 in the coming years. This is a matter of simple probabilities, and not a criticism of Berkshire Hathaway Chairman and CEO ...

Not many stocks on the FTSE 250 have a low valuation, high dividend yield, and solid growth potential. Our writer thinks he’s ...

In a phase 2 study, the company's medication suzetrigine barely performed better than a placebo in treating painful ...